Sign in
4

Changes in Ownership

Edgewise Therapeutics, Inc. Filed Acc 0001562180-22-005386

Options or other derivatives

  • Director acquired 42,087 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Thompson Peter A. · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-06-24 Grant or award : show line 1 in the form Stock Option (Right to Buy) +42,087 42,087 D
Loading xslF345X03/primarydocument.xml…